Form 4 Tracker
Tamar Thompson

Director · 2 filings · Latest: Jul 15, 2026

Avidity Biosciences, Inc.
CATALYST PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RNA
Thompson TamarOct 7, 2024
Proposed Sale
$47.3030,000$1.4M